|
Volumn 12, Issue 3, 2006, Pages 276-277
|
Taking the brake off T cells in chronic viral infection
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIVIRUS AGENT;
CELL ANTIBODY;
CYTOKINE;
PROGRAMMED CELL DEATH 1 ANTIBODY;
UNCLASSIFIED DRUG;
ANTIVIRAL ACTIVITY;
CANCER;
CD4+ T LYMPHOCYTE;
CD8+ T LYMPHOCYTE;
CELL COUNT;
CELL PROLIFERATION;
CELL SPECIFICITY;
COMPARATIVE STUDY;
DOWN REGULATION;
HEPATITIS B;
HEPATITIS C;
IMMUNE RESPONSE;
IMMUNE SYSTEM;
IMMUNOPATHOLOGY;
IMMUNOSUPPRESSIVE TREATMENT;
LYMPHOCYTIC CHORIOMENINGITIS VIRUS;
NONHUMAN;
PATHOGENESIS;
PRIORITY JOURNAL;
SHORT SURVEY;
SPLEEN CELL;
VIRUS INFECTION;
VIRUS MENINGITIS;
ANIMALS;
ARENAVIRIDAE INFECTIONS;
CD8-POSITIVE T-LYMPHOCYTES;
CHRONIC DISEASE;
HUMANS;
LYMPHOCYTIC CHORIOMENINGITIS VIRUS;
HEPATITIS C VIRUS;
LYMPHOCYTIC CHORIOMENINGITIS VIRUS;
|
EID: 33644820218
PISSN: 10788956
EISSN: 1546170X
Source Type: Journal
DOI: 10.1038/nm0306-276 Document Type: Short Survey |
Times cited : (11)
|
References (14)
|